A Study of LY3041658 in Participants With Skin Diseases
Status:
Completed
Trial end date:
2019-03-19
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the safety and tolerability of the study
drug known as LY3041658 in participants with certain types of skin diseases. The study will
measure how the body absorbs, breaks down and gets rid of LY3041658. It will last about 127
days for each participant, not including screening. This study is for research purposes only,
and is not intended to treat any medical condition.